China National Medicines Corp Ltd (600511) - Total Liabilities
Based on the latest financial reports, China National Medicines Corp Ltd (600511) has total liabilities worth CN¥15.19 Billion CNY (≈ $2.22 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore China National Medicines Corp Ltd (600511) long-term investment share to see how much of total assets are deployed in long-term investments.
China National Medicines Corp Ltd - Total Liabilities Trend (1999–2024)
This chart illustrates how China National Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of China National Medicines Corp Ltd.
China National Medicines Corp Ltd Competitors by Total Liabilities
The table below lists competitors of China National Medicines Corp Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Multiplan Empreendimentos Imobiliários S.A
SA:MULT3
|
Brazil | R$6.46 Billion |
|
Shenzhen InfoGem Technologies Co Ltd
SHE:300085
|
China | CN¥480.54 Million |
|
Kyndryl Holdings Inc
NYSE:KD
|
USA | $9.97 Billion |
|
Lisi S.A
PA:FII
|
France | €1.30 Billion |
|
Sportradar Group AG
NASDAQ:SRAD
|
USA | $1.78 Billion |
|
Van Lanschot NV
AS:VLK
|
Netherlands | €16.50 Billion |
|
Inter Parfums Inc
NASDAQ:IPAR
|
USA | $430.23 Million |
|
KPJ Healthcare Bhd
KLSE:5878
|
Malaysia | RM4.97 Billion |
Liability Composition Analysis (1999–2024)
This chart breaks down China National Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See China National Medicines Corp Ltd balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how China National Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for China National Medicines Corp Ltd (1999–2024)
The table below shows the annual total liabilities of China National Medicines Corp Ltd from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥15.95 Billion ≈ $2.33 Billion |
+6.93% |
| 2023-12-31 | CN¥14.92 Billion ≈ $2.18 Billion |
+8.51% |
| 2022-12-31 | CN¥13.75 Billion ≈ $2.01 Billion |
+4.80% |
| 2021-12-31 | CN¥13.12 Billion ≈ $1.92 Billion |
+11.08% |
| 2020-12-31 | CN¥11.81 Billion ≈ $1.73 Billion |
-1.86% |
| 2019-12-31 | CN¥12.03 Billion ≈ $1.76 Billion |
+10.41% |
| 2018-12-31 | CN¥10.90 Billion ≈ $1.60 Billion |
+1.78% |
| 2017-12-31 | CN¥10.71 Billion ≈ $1.57 Billion |
+216.41% |
| 2016-12-31 | CN¥3.38 Billion ≈ $495.28 Million |
+11.27% |
| 2015-12-31 | CN¥3.04 Billion ≈ $445.10 Million |
+2.86% |
| 2014-12-31 | CN¥2.96 Billion ≈ $432.71 Million |
+2.55% |
| 2013-12-31 | CN¥2.88 Billion ≈ $421.94 Million |
+7.20% |
| 2012-12-31 | CN¥2.69 Billion ≈ $393.60 Million |
+33.24% |
| 2011-12-31 | CN¥2.02 Billion ≈ $295.41 Million |
-1.50% |
| 2010-12-31 | CN¥2.05 Billion ≈ $299.92 Million |
+21.01% |
| 2009-12-31 | CN¥1.69 Billion ≈ $247.84 Million |
+50.07% |
| 2008-12-31 | CN¥1.13 Billion ≈ $165.15 Million |
-8.24% |
| 2007-12-31 | CN¥1.23 Billion ≈ $179.99 Million |
+59.53% |
| 2006-12-31 | CN¥771.05 Million ≈ $112.83 Million |
+1.55% |
| 2005-12-31 | CN¥759.27 Million ≈ $111.11 Million |
+7.78% |
| 2004-12-31 | CN¥704.48 Million ≈ $103.09 Million |
+13.66% |
| 2003-12-31 | CN¥619.80 Million ≈ $90.70 Million |
+51.63% |
| 2002-12-31 | CN¥408.75 Million ≈ $59.81 Million |
+35.80% |
| 2001-12-31 | CN¥300.99 Million ≈ $44.04 Million |
+16.51% |
| 2000-12-31 | CN¥258.33 Million ≈ $37.80 Million |
-42.44% |
| 1999-12-31 | CN¥448.80 Million ≈ $65.67 Million |
-- |
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more